Current Affairs

Cancer Drug Price Caps

2.2 Governance, Indian Express, 2026-11-11

Capping of trade margins on 137 cancer drugs took effect on Monday, with an average reduction of almost Rs 6,000, per the National Pharmaceutical Pricing Authority (NPPA) list covering 1,366 formulations. Prices of 201 formulations did not change, and 255 fell by less than Rs100. Only four of 57 formulations costing over Rs 1 lakh per unit saw a price fall. 62 formulations of 39 patented, single source drugs such as pembrolizumab saw no change. Enzalutamide (Astellas Pharma) dropped by around Rs 2 lakh under trade margin rationalisation (TMR).